Back to search
Phlebotomy Dependent Polycythemia Vera
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Phlebotomy Dependent Polycythemia Vera trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Phlebotomy Dependent Polycythemia Vera trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The main purpose of this study is to evaluate the efficacy of sapablursen in reducing the frequency of phlebotomy and in improving quality of life assessments i…
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with phlebotomy-dependent polycythemia vera (PV). Inh…